The whole truth and nothing but the truth? The research that Philip Morris did not want you to see

被引:78
作者
Diethelm, PA [1 ]
Rielle, JC
McKee, M
机构
[1] OxyRomandie, Geneva, Switzerland
[2] Carrefour Prevent, CIPRET Geneve, Geneva, Switzerland
[3] London Sch Hyg & Trop Med, London WC1, England
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0140-6736(05)66474-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The tobacco industry maintained, for many years, that it was unaware of research about the toxic effects of smoking. By the 1970s, however, the industry decided that it needed this information but they were unwilling to seek it in a way that was open to public scrutiny. By means of material from internal industry documents it can be revealed that one company, Philip Morris, acquired a research facility, INBIFO, in Germany and created a complex mechanism seeking to ensure that the work done in the facility could not be linked to Philip Morris. In particular it involved the appointment of a Swedish professor as a 'co-ordinator', who would synthesise reports for onward transmission to the USA. Various arrangements were made to conceal this process, not only from the wider public, but also from many within Philip Morris, although it was known to some senior executives. INBIFO appears to have published only a small amount of its research and what was published appears to differ considerably from what was not. In particular, the unpublished reports provided evidence of the greater toxicity of sidestream. than mainstream smoke, a finding of particular relevance given the industry's continuing denial of the harmful effects of passive smoking. By contrast, much of its published work comprises papers that convey a message that could be considered useful to the industry, in particular casting doubt on methods used to assess the effects of passive smoking.
引用
收藏
页码:86 / 92
页数:7
相关论文
共 40 条
[1]  
*AM TOB CO, 1967, NIC PROD FEAS STUD
[2]   Industry-funded research and conflict of interest: An analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research [J].
Barnes, DE ;
Bero, LA .
JOURNAL OF HEALTH POLITICS POLICY AND LAW, 1996, 21 (03) :515-542
[3]  
CARCHMAN RA, 1997, SCI PUBLICATION
[4]  
CRAMPTON WJ, 1990, RE DISCOVERY RES DOC
[5]  
CULLMAN JF, 1969, COMMUNICATION 1007
[6]  
CULLMAN JF, 1970, COMMUNICATION 0224
[7]   Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents [J].
Drope, J ;
Chapman, S .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2001, 55 (08) :588-594
[8]  
DUNN WL, 1980, NICOTINE RECEPTOR PR
[9]   Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98 [J].
Enstrom, JE ;
Kabat, GC .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7398) :1057-+
[10]   The activity of NF-κB in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke is dependent on thioredoxin [J].
Gebel, S ;
Müller, T .
TOXICOLOGICAL SCIENCES, 2001, 59 (01) :75-81